Comparison of classification methods that combine clinical data and high-dimensional mass spectrometry data

BACKGROUND: The identification of new diagnostic or prognostic biomarkers is one of the main aims of clinical cancer research. Technologies like mass spectrometry are commonly being used in proteomic research. Mass spectrometry signals show the proteomic profiles of the individuals under study at a...

Descripción completa

Detalles Bibliográficos
Autores principales: Truntzer, Caroline, Mostacci, Elise, Jeannin, Aline, Petit, Jean-Michel, Ducoroy, Patrick, Cardot, Hervé
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2014
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4261611/
https://www.ncbi.nlm.nih.gov/pubmed/25432156
http://dx.doi.org/10.1186/s12859-014-0385-z

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4261611/
https://www.ncbi.nlm.nih.gov/pubmed/25432156
http://dx.doi.org/10.1186/s12859-014-0385-z

Ejemplares similares